TrialClinical cancer research : an official journal of the American Association for Cancer Research2013

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.

Amanda Eustace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.